The concept is based on directed drug delivery using specific siRNA and vitamin A derivatives. Clinical collaboration is with Sapporo Medical University.
Nitto Denko news release, April 22, 2014
Nitto Denko completes Phase I study of siRNA candidate to treat fibrotic diseases such as liver cirrhosis